These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20608290)
1. The changing landscape of US drug discovery research. Desai MC; Chackalamannil S Curr Opin Drug Discov Devel; 2010 Jul; 13(4):376-8. PubMed ID: 20608290 [No Abstract] [Full Text] [Related]
2. Mark McClellan. Interview by Asher Mullard. McClellan M Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796 [No Abstract] [Full Text] [Related]
4. Drug development needs a new brand of science. Fitzgerald G Nature; 2010 Dec; 468(7326):869. PubMed ID: 21164436 [No Abstract] [Full Text] [Related]
5. Chutes and ladders on the critical path:comparative effectiveness, product value, and the use of biomarkers in drug development. Woodcock J Clin Pharmacol Ther; 2009 Jul; 86(1):12-4. PubMed ID: 19536116 [No Abstract] [Full Text] [Related]
6. Value networks identify innovation in 21st century pharmaceutical research. Edwards PJ Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823 [TBL] [Abstract][Full Text] [Related]
7. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319 [TBL] [Abstract][Full Text] [Related]
8. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
9. Menelas Pangalos. Interview by Asher Mullard. Mullard A Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338 [No Abstract] [Full Text] [Related]
10. Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development. Kearns GL Biomark Med; 2010 Dec; 4(6):783-6. PubMed ID: 21133695 [No Abstract] [Full Text] [Related]
12. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. Camilleri M Curr Opin Pharmacol; 2008 Dec; 8(6):671-6. PubMed ID: 18588997 [TBL] [Abstract][Full Text] [Related]
13. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science. Woosley RL; Myers RT; Goodsaid F Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457 [TBL] [Abstract][Full Text] [Related]
14. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
15. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development. Perakslis ED; Van Dam J; Szalma S Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001 [No Abstract] [Full Text] [Related]
16. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France. Napper AD IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316 [No Abstract] [Full Text] [Related]
17. [Advance in the research and discovery of novel drugs based on chemogenomics]. He BK; Ma ZC; Wang YG; Gao Y Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023 [TBL] [Abstract][Full Text] [Related]
18. Virtual drug discovery with the rise of Chinese CROs. Zhang MQ Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343 [No Abstract] [Full Text] [Related]
19. Christian K. Schneider. Interview by Bethan Hughes. Schneider CK Nat Rev Drug Discov; 2009 Apr; 8(4):270. PubMed ID: 19337268 [No Abstract] [Full Text] [Related]
20. Drug discovery goes back to school: changing ecosystem of drug discovery and the rising role of academia. Slusher B J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2():S2-4. PubMed ID: 25269734 [No Abstract] [Full Text] [Related] [Next] [New Search]